Chargement en cours...
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid
Histone deacetylase (HDAC) proteins have emerged as targets for anti-cancer therapeutics, with several inhibitors used in the clinic, including suberoylanilide hydroxamic acid (SAHA, vorinostat). Because SAHA and many other inhibitors target all or most of the 11 human HDAC proteins, the creation of...
Enregistré dans:
| Publié dans: | Arch Pharm (Weinheim) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927578/ https://ncbi.nlm.nih.gov/pubmed/27062198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ardp.201500472 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|